Explore Our Pipeline Latest News 03.07.2025 Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting Read Press Release View All News View Corporate Deck
Explore Our Pipeline Latest News 02.19.2025 Oruka Therapeutics to Present at Multiple March Investor Conferences Read Press Release View All News View Corporate Deck
简介:Oruka Therapeutics, Inc.是一家生物制药公司,该公司主要致力于心血管疾病的基因疗法。公司的领先候选产品是Gencaro TM,一种有效的β受体阻滞剂同时还是温和的血管舒张药,正被开发用于治疗心房纤维颤动患者的心脏衰竭。公司已经识别出在心血管系统中常见的基因变异,并认为这与Gencaro的药理有关,并能预测病人对药物...
华盛通为您提供Oruka Therapeutics, Inc. - Common Stock(ORKA)股票股价,实时行情,新闻,财报,研究报告,财务指标分析等与Oruka Therapeutics, Inc. - Common Stock(ORKA)股票相关的信息与服务
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody Dec 19, 2024 Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI) Dec 18, 2024 Oruka Therapeutics to Present at Piper Sandler’s 36th...
Oruka Therapeutics, Inc.添加自选 US ORKA NLS基础行情 纳斯达克交易所 所属行业 10.640 美元 -0.220 -2.03%已收盘 02-25 16:00:00 美东时间 11.290 美元 +0.65 +6.11% 盘前 02-26 04:13:13 美东时间 概览 资金 简况 股评 资讯 财务 分析 ...
ORKA | Complete Oruka Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
ORKA | Complete Oruka Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
HC Wainwright & Co.:重申Oruka Therapeutics(ORKA.US)评级,由买入调整至买入评级, 目标价由45.00美元调整至45.00美元。 Oruka Therapeutics(ORKA.US)公司简介:Oruka Therapeutics Inc 正在开发新型生物制剂,旨在为慢性皮肤病的治疗制定新标准。 它为患有斑块状牛皮癣等慢性皮肤病的患者提供服务。
Oruka Therapeutics’s ORKA-001: Promising Psoriasis Treatment Drives Buy Rating with 12-Month Price Target of $45 Dec. 20, 2024 at 1:25 p.m. ETon TipRanks.com Analysts Have Conflicting Sentiments on These Healthcare Companies: Celldex (CLDX), Oruka Therapeutics (ORKA) and Adicet Bio (ACET...